The clinical impact of using complex molecular profiling strategies in routine oncology practice-Reference-Cited by-同舟云学术

The clinical impact of using complex molecular profiling strategies in routine oncology practice

Published:2018-04-17 Issue:29 Volume:9 Page:20282-20293
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Laes Jean-François¹,Aftimos Philippe²,Barthelemy Philippe³,Bellmunt Joaquim⁴,Berchem Guy⁵,Camps Carlos,Peñas Ramón de las⁶,Finzel Ana¹,García-Foncillas Jesús⁷,Hervonen Petteri,Wahid Ibrahim,Joensuu Timo,Kathan Louis,Kong Anthony,Mackay James,Mikropoulos Christos,Mokbel Kefah,Mouysset Jean-Loup,Odarchenko Sergey,Perren Timothy J.,Pienaar Rika,Regonesi Carlos,Alkhayyat Shadi Salem,El Kinge Abdul Rahman,Abulkhair Omalkhair,Galal Khaled Morsi,Ghanem Hady,El Karak Fadi,Garcia Angel,Ghitti Gregori¹,Sadik Helen¹

Affiliation:

1. OncoDNA SA, Office: 1, Rue Louis Breguet, Gosselies, Belgium

2. Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium

3. Hôpitaux Universitaires de Strasbourg, Strasbourg, France

4. Institut Hospital del Mar d’Investigacions Médiques, Barcelona, Spain

5. Centre Hospitalier de Luxembourg, Luxembourg, Luxembourg

6. Consorcio Hospitalario Provincial de Castellón, Castellón, Spain

7. Fundación Jimenez Díaz, IDC Salud, Madrid, Spain

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Beyond traditional therapies: clinical significance of complex molecular profiling in patients with advanced solid tumours—results from a Turkish multi-centre study;Japanese Journal of Clinical Oncology;2024-01-25

2. Challenges in integrating molecular profiles into clinical cancer care;memo - Magazine of European Medical Oncology;2022-10-06

3. What are the challenges with multi-targeted drug design for complex diseases?;Expert Opinion on Drug Discovery;2022-05-12

4. New strategies of clinical precision medicine;Clinical and Translational Medicine;2022-02

5. Mutational Landscape and Actionable Target Rates on Advanced Stage Refractory Cancer Patients: A Multicenter Chilean Experience;Journal of Personalized Medicine;2022-01-31